David Dornan insider trades
Open-market stock purchases and sales by David Dornan, Chief Scientific Officer at Whitehawk Therapeutics, Inc, from SEC Form 4 filings since Feb 4, 2021.
Open-market stock purchases and sales by David Dornan, Chief Scientific Officer at Whitehawk Therapeutics, Inc, from SEC Form 4 filings since Feb 4, 2021.